Rudman Errol M Upped Position in Health Ins Innovations (HIIQ) by $312,000; Regeneron Pharmaceuticals (REGN) Shareholder Grandfield & Dodd Raised Stake by $567,706

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Logo

Grandfield & Dodd Llc increased its stake in Regeneron Pharmaceuticals (REGN) by 21.22% based on its latest 2018Q4 regulatory filing with the SEC. Grandfield & Dodd Llc bought 1,522 shares as the company’s stock rose 19.30% with the market. The institutional investor held 8,695 shares of the health care company at the end of 2018Q4, valued at $3.25 million, up from 7,173 at the end of the previous reported quarter. Grandfield & Dodd Llc who had been investing in Regeneron Pharmaceuticals for a number of months, seems to be bullish on the $37.86 billion market cap company. The stock decreased 5.36% or $19.72 during the last trading session, reaching $347.97. About 1.16 million shares traded or 64.56% up from the average. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has risen 34.82% since April 17, 2018 and is uptrending. It has outperformed by 30.45% the S&P500. Some Historical REGN News: 01/05/2018 – Regeneron and Sanofi to Lower Net Price of Praluent (alirocumab) Injection in Exchange for Straightforward, More Affordable Patient Access for Express Scripts Patients; 16/05/2018 – POSITIVE PHASE 3 TRIAL OF DUPIXENT® (DUPILUMAB) IN ADOLESCENTS WITH INADEQUATELY CONTROLLED MODERATE-TO-SEVERE ATOPIC DERMATITIS; 15/05/2018 – Regeneron Presenting at Bank of America Conference Tomorrow; 03/05/2018 – Regeneron’s first quarter profit soars 92 percent; 01/05/2018 – Regeneron and Sanofi to Lower Net Price of Praluent® (alirocumab) Injection in Exchange for Straightforward, More Affordable P; 21/03/2018 – REGENERON & ALNYLAM: PACT TO DISCOVER NEW TREATMENTS FOR NASH; 15/05/2018 – Partner Fund Adds Bristol-Myers, Exits Regeneron: 13F; 10/03/2018 – REG-Sanofi and Regeneron announce plans to make Praluent® more accessible and affordable for patients with the greatest health risk and unmet need; 27/04/2018 – Regeneron Investors Brace for Ugly Earnings as Concerns Mount; 10/05/2018 – @JimCramer vets biotech giants Biogen, Celgene, Gilead and Regeneron for positive prospects

Rudman Errol M increased its stake in Health Ins Innovations Inc (HIIQ) by 13.62% based on its latest 2018Q4 regulatory filing with the SEC. Rudman Errol M bought 12,000 shares as the company’s stock rose 7.47% with the market. The institutional investor held 100,108 shares of the finance company at the end of 2018Q4, valued at $2.68M, up from 88,108 at the end of the previous reported quarter. Rudman Errol M who had been investing in Health Ins Innovations Inc for a number of months, seems to be bullish on the $365.89 million market cap company. The stock decreased 0.39% or $0.1 during the last trading session, reaching $24.1. About 611,412 shares traded. Health Insurance Innovations, Inc. (NASDAQ:HIIQ) has risen 11.00% since April 17, 2018 and is uptrending. It has outperformed by 6.63% the S&P500. Some Historical HIIQ News: 23/05/2018 – Health Insurance Innovations Presenting at Conference Tomorrow; 02/05/2018 – Health Insur Innovations 1Q Adj EPS 52c; 02/05/2018 – Health Insur Innovations 1Q Rev $67.8M; 09/05/2018 – AgileHealthlnsurance Report: Price Advantage of Short-Term Health Insurance Over Obamacare Widens in 2018; 02/05/2018 – HEALTH INSURANCE INNOVATIONS: NO FINDINGS COMMUNICATED YET; 14/03/2018 – Scott+Scott Attorneys at Law LLP is Investigating Derivative Claims on Behalf of Shareholders of Health Insurance Innovations, Inc. (HIIQ); 02/05/2018 – Health Insur Innovations 1Q EPS 33c; 10/05/2018 – Tieton Capital Buys Into Health Insurance Innovations Class A; 08/03/2018 Health Insurance Innovations at Company Marketing Hosted By FBR; 14/03/2018 – Scott+Scott Attorneys at Law LLP is Investigating Derivative Claims on Behalf of Shareholders of Health Insurance Innovations,

More notable recent Health Insurance Innovations, Inc. (NASDAQ:HIIQ) news were published by: Seekingalpha.com which released: “Health Insurance Innovations, Inc. (HIIQ) CEO Gavin Southwell on Q3 2018 Results – Earnings Call Transcript – Seeking Alpha” on October 30, 2018, also Globenewswire.com with their article: “Health Insurance Innovations, Inc. Provides Business Update for Q4 2018 Ahead of Analyst Day – GlobeNewswire” published on December 20, 2018, Seekingalpha.com published: “Trump: Obamacare replacement will come after election – Seeking Alpha” on April 02, 2019. More interesting news about Health Insurance Innovations, Inc. (NASDAQ:HIIQ) were released by: Nasdaq.com and their article: “Is Health Insurance Innovations (HIIQ) a Solid Growth Stock? 3 Reasons to Think ” Yes ” – Nasdaq” published on March 29, 2019 as well as Benzinga.com‘s news article titled: “31 Stocks Moving In Thursday’s Pre-Market Session – Benzinga” with publication date: March 21, 2019.

Investors sentiment decreased to 1.31 in 2018 Q4. Its down 0.02, from 1.33 in 2018Q3. It worsened, as 28 investors sold HIIQ shares while 31 reduced holdings. 38 funds opened positions while 39 raised stakes. 15.37 million shares or 26.20% more from 12.18 million shares in 2018Q3 were reported. First Tru Advisors Ltd Partnership has invested 0% in Health Insurance Innovations, Inc. (NASDAQ:HIIQ). Cannell Ltd Liability Co has 5.8% invested in Health Insurance Innovations, Inc. (NASDAQ:HIIQ). Kornitzer Capital Mngmt Incorporated Ks owns 240,740 shares for 0.13% of their portfolio. Alphamark Advsrs Limited Liability Company stated it has 0.29% in Health Insurance Innovations, Inc. (NASDAQ:HIIQ). The New York-based Secor Cap Advsr Ltd Partnership has invested 0.04% in Health Insurance Innovations, Inc. (NASDAQ:HIIQ). Moreover, Connor Clark & Lunn Invest Ltd has 0% invested in Health Insurance Innovations, Inc. (NASDAQ:HIIQ) for 16,992 shares. Old Second State Bank Of Aurora holds 2,582 shares. Marshall Wace Limited Liability Partnership reported 0.08% in Health Insurance Innovations, Inc. (NASDAQ:HIIQ). Intll Group Incorporated owns 0% invested in Health Insurance Innovations, Inc. (NASDAQ:HIIQ) for 8,508 shares. Harvest Strategies Ltd holds 7.09% in Health Insurance Innovations, Inc. (NASDAQ:HIIQ) or 950,000 shares. Axa accumulated 61,800 shares. Emerald Mutual Fund Advisers holds 134,166 shares. 14,625 were reported by Monarch Ptnrs Asset Ltd Com. State Board Of Administration Of Florida Retirement reported 8,104 shares. Credit Suisse Ag holds 0% of its portfolio in Health Insurance Innovations, Inc. (NASDAQ:HIIQ) for 13,222 shares.

Since December 17, 2018, it had 4 insider purchases, and 2 selling transactions for $1.90 million activity. GABOS PAUL G had bought 8,000 shares worth $239,254 on Wednesday, March 20. $200,510 worth of Health Insurance Innovations, Inc. (NASDAQ:HIIQ) was bought by Murley Robert S on Monday, December 17. On Friday, February 1 the insider Southwell Gavin sold $3.21 million. $2.75 million worth of stock was bought by FICHTHORN JOHN on Wednesday, March 20. Hershberger Michael D also sold $1.97 million worth of Health Insurance Innovations, Inc. (NASDAQ:HIIQ) shares.

Rudman Errol M, which manages about $143.27M US Long portfolio, decreased its stake in Floor & Decor Hldgs Inc by 90,000 shares to 56,895 shares, valued at $1.47 million in 2018Q4, according to the filing. It also reduced its holding in Spdr Series Trust (XOP) by 30,500 shares in the quarter, leaving it with 51,000 shares, and cut its stake in Centene Corp Del (NYSE:CNC).

Since December 12, 2018, it had 0 buys, and 4 sales for $55.44 million activity. Fenimore Christopher R. had sold 1,848 shares worth $663,381 on Wednesday, December 19. Another trade for 6 shares valued at $2,294 was made by VAGELOS P ROY on Wednesday, December 12. Shares for $54.04M were sold by Sanofi.

Grandfield & Dodd Llc, which manages about $885.55 million and $844.97 million US Long portfolio, decreased its stake in Exxon Mobil Corp (NYSE:XOM) by 10,422 shares to 216,487 shares, valued at $14.76 million in 2018Q4, according to the filing. It also reduced its holding in At&T Inc (NYSE:T) by 70,704 shares in the quarter, leaving it with 38,946 shares, and cut its stake in Stryker Corp (NYSE:SYK).

Investors sentiment decreased to 1.13 in Q4 2018. Its down 0.01, from 1.14 in 2018Q3. It fall, as 52 investors sold REGN shares while 165 reduced holdings. 72 funds opened positions while 174 raised stakes. 77.33 million shares or 9.82% more from 70.41 million shares in 2018Q3 were reported. Amundi Pioneer Asset Mgmt holds 0.08% or 230,687 shares. Bennicas Assocs reported 1,805 shares or 0.62% of all its holdings. Rhumbline Advisers has invested 0.12% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Zeke Cap Advisors Ltd has invested 0.08% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Grandfield Dodd invested in 0.38% or 8,695 shares. Los Angeles Mgmt & Equity Rech owns 74,752 shares or 0.17% of their US portfolio. Retail Bank Of Ny Mellon accumulated 591,843 shares or 0.07% of the stock. Ohio-based Bowling Portfolio Mngmt Ltd Liability Co has invested 0.32% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Kentucky Retirement Sys reported 0.14% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Blair William & Company Il holds 0% or 1,175 shares. 535 are held by C M Bidwell Limited. Chicago Equity Prtn Ltd Liability invested 0.1% of its portfolio in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Focused Wealth Mngmt Inc owns 9 shares or 0% of their US portfolio. 988 are held by Comerica Secs. 147,074 are owned by Canada Pension Plan Investment Board.

Health Insurance Innovations, Inc. (NASDAQ:HIIQ) Institutional Positions Chart